Le Gjerum

504 total citations
24 papers, 279 citations indexed

About

Le Gjerum is a scholar working on Dermatology, Physiology and Immunology and Allergy. According to data from OpenAlex, Le Gjerum has authored 24 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Dermatology, 12 papers in Physiology and 12 papers in Immunology and Allergy. Recurrent topics in Le Gjerum's work include Dermatology and Skin Diseases (14 papers), Dementia and Cognitive Impairment Research (10 papers) and Food Allergy and Anaphylaxis Research (8 papers). Le Gjerum is often cited by papers focused on Dermatology and Skin Diseases (14 papers), Dementia and Cognitive Impairment Research (10 papers) and Food Allergy and Anaphylaxis Research (8 papers). Le Gjerum collaborates with scholars based in Denmark, United Kingdom and Italy. Le Gjerum's co-authors include Kristian Steen Frederiksen, Steen Gregers Hasselbalch, Gunhild Waldemar, Gunhild Waldemar, Juha Koikkalainen, Marie Bruun, Jyrki Lötjönen, Patrizia Mecocci, Marta Baroni and Hidehisa Saeki and has published in prestigious journals such as PLoS ONE, Journal of the American Academy of Dermatology and British Journal of Dermatology.

In The Last Decade

Le Gjerum

18 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Le Gjerum Denmark	7	103	102	67	57	42	24	279
Shouhai Hong China	10	43 0.4×	57 0.6×	20 0.3×	8 0.1×	35 0.8×	22	321
M. Thomas Sweden	7	48 0.5×	62 0.6×	47 0.7×	28 0.5×	15 0.4×	8	353
Katja Wruck Germany	5	86 0.8×	42 0.4×	30 0.4×	28 0.5×	9 0.2×	7	667
Leixiao Zhang China	9	32 0.3×	23 0.2×	58 0.9×	12 0.2×	14 0.3×	39	317
C. LʼHéritier France	9	47 0.5×	60 0.6×	85 1.3×	60 1.1×	4 0.1×	14	300
Margaret Lessard United States	5	39 0.4×	195 1.9×	13 0.2×	6 0.1×	16 0.4×	7	338
Zhongyu Zhou China	10	60 0.6×	98 1.0×	8 0.1×	3 0.1×	27 0.6×	38	433
Sigrid Mank Germany	2	56 0.5×	30 0.3×	10 0.1×	10 0.2×	8 0.2×	2	401
Aldo Liguori Italy	8	73 0.7×	42 0.4×	17 0.3×	22 0.4×	9 0.2×	18	294
S Jena Germany	7	146 1.4×	51 0.5×	9 0.1×	10 0.2×	6 0.1×	18	760

Countries citing papers authored by Le Gjerum

Since Specialization

Citations

This map shows the geographic impact of Le Gjerum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Le Gjerum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Le Gjerum more than expected).

Fields of papers citing papers by Le Gjerum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Le Gjerum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Le Gjerum. The network helps show where Le Gjerum may publish in the future.

Co-authorship network of co-authors of Le Gjerum

This figure shows the co-authorship network connecting the top 25 collaborators of Le Gjerum. A scholar is included among the top collaborators of Le Gjerum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Le Gjerum. Le Gjerum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chovatiya, Raj, Simone Ribero, Andreas Wollenberg, et al.. (2025). Long-Term Disease Control and Minimal Disease Activity of Head and Neck Atopic Dermatitis in Patients Treated with Tralokinumab up to 4 Years. PubMed. 26(4). 587–601. 6 indexed citations

Reich, Kristian, Richard G. Langley, J.F. Silvestre, et al.. (2025). Safety of tralokinumab in patients with moderate-to-severe atopic dermatitis followed for up to 4.5 years: an integrated analysis of eight clinical trials. British Journal of Dermatology. 194(2). 225–235.

Reich, Kristian, Richard G. Langley, D. Staumont‐Sallé, et al.. (2024). Safety of Tralokinumab for the Treatment of Atopic Dermatitis in Patients with Up to 4.5 Years of Treatment: An Updated Integrated Analysis of Eight Clinical Trials. SKIN The Journal of Cutaneous Medicine. 8(2). s375–s375. 2 indexed citations

Reich, Kristian, Richard G. Langley, D. Staumont‐Sallé, et al.. (2024). 555 - Safety of tralokinumab for the treatment of atopic dermatitis in patients with up to 4.5 years of treatment: an updated integrated analysis of eight clinical trials. British Journal of Dermatology. 190(Supplement_2). ii52–ii53. 1 indexed citations

Blauvelt, Andrew, Chih-ho Hong, Ketty Peris, et al.. (2024). Stability of Long-Term Therapeutic Responses to Tralokinumab in Adults with Moderate-to-Severe Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine. 8(4). s412–s412.

Blauvelt, Andrew, Hwanhee Hong, Ketty Peris, et al.. (2024). 650 - Stability of long-term therapeutic responses to tralokinumab in adults with moderate-to-severe atopic dermatitis. British Journal of Dermatology. 191(Supplement_2). 1 indexed citations

Blauvelt, Andrew, Richard G. Langley, Ketty Peris, et al.. (2024). 551 - Continuous tralokinumab treatment over 4 years in adults with moderate-to-severe atopic dermatitis provides long-term disease control. British Journal of Dermatology. 190(Supplement_2). ii48–ii49. 2 indexed citations

Reich, Kristian, Richard G. Langley, D. Staumont‐Sallé, et al.. (2024). 649 - Safety of tralokinumab for the treatment of atopic dermatitis in patients with up to 4.5 years of treatment: an updated integrated analysis of eight clinical trials. British Journal of Dermatology. 191(Supplement_2). 2 indexed citations

Reich, Kristian, Eric L. Simpson, Richard G. Langley, et al.. (2023). Tralokinumab demonstrated a consistent safety profile with up to 42 months of treatment in moderate to severe atopic dermatitis: including adverse events of special interest. SKIN The Journal of Cutaneous Medicine. 7(2). s143–s143. 1 indexed citations

10.

Khemis, A., Eric L. Simpson, Andreas Wollenberg, et al.. (2023). Tolérance et efficacité à long terme du tralokinumab chez des adolescents atteints de dermatite atopique modérée à sévère : analyse intermédiaire d’ECZTEND. 3(8). A363–A364.

11.

Blauvelt, Andrew, Richard G. Langley, J.‐P. Lacour, et al.. (2022). Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial. Journal of the American Academy of Dermatology. 87(4). 815–824. 48 indexed citations

12.

Blauvelt, Andrew, Andrew Pink, Margitta Worm, et al.. (2022). Outcomes of COVID-19 and Vaccination in Patients With Moderate to Severe Atopic Dermatitis Treated With Tralokinumab. JAMA Dermatology. 158(11). 1327–1327. 5 indexed citations

13.

Bruun, Marie, Le Gjerum, Kristian Steen Frederiksen, et al.. (2021). Comparing a Single Clinician Versus a Multidisciplinary Consensus Conference Approach for Dementia Diagnostics. Journal of Alzheimer s Disease. 83(2). 741–751. 6 indexed citations

14.

Gjerum, Le, Birgitte Andersen, Marie Bruun, et al.. (2021). Comparison of the clinical impact of 2-[18F]FDG-PET and cerebrospinal fluid biomarkers in patients suspected of Alzheimer’s disease. PLoS ONE. 16(3). e0248413–e0248413. 6 indexed citations

15.

Gjerum, Le, Kristian Steen Frederiksen, Otto Mølby Henriksen, et al.. (2020). Evaluating 2-[18F]FDG-PET in differential diagnosis of dementia using a data-driven decision model. NeuroImage Clinical. 27. 102267–102267. 13 indexed citations

16.

Gjerum, Le, Juha Koikkalainen, Jyrki Lötjönen, et al.. (2020). Prognostic value of complementary biomarkers of neurodegeneration in a mixed memory clinic cohort. PeerJ. 8. e9498–e9498. 6 indexed citations

17.

Bruun, Marie, Juha Koikkalainen, Hanneke Rhodius‐Meester, et al.. (2019). Detecting frontotemporal dementia syndromes using MRI biomarkers. NeuroImage Clinical. 22. 101711–101711. 44 indexed citations

18.

Gjerum, Le, Kristian Steen Frederiksen, Otto Mølby Henriksen, et al.. (2019). A visual rating scale for cingulate island sign on 18F-FDG-PET to differentiate dementia with Lewy bodies and Alzheimer's disease. Journal of the Neurological Sciences. 410. 116645–116645. 16 indexed citations

19.

Frederiksen, Kristian Steen, Le Gjerum, Gunhild Waldemar, & Steen Gregers Hasselbalch. (2019). Physical Activity as a Moderator of Alzheimer Pathology: A Systematic Review of Observational Studies. Current Alzheimer Research. 16(4). 362–378. 31 indexed citations

20.

Bruun, Marie, Hanneke Rhodius‐Meester, Juha Koikkalainen, et al.. (2018). Evaluating combinations of diagnostic tests to discriminate different dementia types. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 10(1). 509–518. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact